Page 107 - 2017食品藥物管理署年報(英文版)

2017 Taiwan Food and Drug Administration Annual Report Chapter 7. International Cooperation and Cross-strait Exchanges

testing, the preparation of international viral standards of blood-borne pathogens
by NIBSC and the most updated technology in nucleic acid amplification
techniques and genetic sequencing analysis.

(3) Cosmetics area
Attending Global Summit on Regulatory Science (GSRS) hosted by US FDA
between September 5-11, 2016. The theme was the standards and applications of
nanotechnology. TFDA oral presented 2 articles on the meeting and communicated with
international experts.

3. Bilateral activities (including signing related agreements and

Memorandum of Understanding (MOU))
(1) Taiwan and Poland signed “TAIWAN-POLAND Medicinal Products and Medical
Devices Memorandum of Understanding (MOU)” on January 14, 2016 and
successfully expanded our international collaborations. The MOU allows both
parties exchanging information regarding medicinal products and medical device

pre-marketing management and clinical trials, so industry may have provision
harmonization, improved efficiency and predictable benefits; in the meanwhile, the
public may access to safe and good quality medicinal products.

(2) Attend Taiwan-EU Economic and Trade Consultation Pharma Working Group
Meeting on April 27 and October 12, 2016, so both sides exchanged opinions about
strengthening medical devices and cosmetics laws, administrative legal entities and
bilateral collaborations.

(3) TFDA firstly designates a staff to attend “The 1 Europe cosmetics testing technology
st
symposium” and “The 13 meeting of the Laboratory Network of Official Cosmetics
th
Control Laboratories” hosted by the European Network of Official Cosmetics
Control Laboratories (OCCLs) between June 14-19, 2016. Attend “The 5 European
th
Union post-marketing surveillance platform meeting of cosmetic product analysis”

and “The 14 European Network of Official Cosmetics Control Laboratories” hosted
th
by the OCCLs between December 4-9 to establish communication channels for
exchanging international cosmetics management regulations, standards and testing
methods.

(4) TFDA attended Nation Institution of Infection Disease (NIID) in Japan from June 26
to July 9, 2016 to demonstrate critical technology of novel virus-inactivation tests
and the Plaque reduction neutralization test (PRNT) of JapENnc.

105